id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0341-0001,FDA,FDA-2008-N-0341,Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs,Rule,NFR-Notice of Final Rule,2008-09-29T04:00:00Z,2008,9,2008-09-29T04:00:00Z,2008-12-16T04:59:59Z,2009-02-06T16:52:46Z,E8-22833,0,0,090000648072c51b
FDA-2008-N-0341-0002,FDA,FDA-2008-N-0341,Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs; Companion Document to Direct Final Rule,Proposed Rule,NPR-Notice of Proposed Rule-Making,2008-09-29T04:00:00Z,2008,9,2008-09-29T04:00:00Z,2008-12-16T04:59:59Z,2009-02-06T16:53:12Z,E8-22829,0,0,090000648072c548